GLP-1 Telehealth in 2026: Which States Have New Restrictions?
Telehealth prescribing laws for GLP-1 medications are evolving faster than most providers' compliance teams can track. Several states introduced or tightened restrictions during late 2025 and into 2026, creating a patchwork of rules that affects which providers can serve which patients.
If you've been told your state "isn't available" by one provider but works fine with another, this is probably why.
The Federal Landscape
At the federal level, GLP-1 receptor agonists are not classified as controlled substances. This means the DEA's telehealth prescribing rules for controlled substances (which require in-person visits in many cases) don't apply. However, individual states can and do impose their own requirements for telehealth prescribing of any medication.
The FDA's March 2026 enforcement wave — 30 warning letters to telehealth companies over misleading compounded GLP-1 marketing — also signals increased federal scrutiny of the industry regardless of state-level rules.
States to Watch
Several states have introduced or tightened telehealth prescribing requirements that specifically affect GLP-1 access:
- States requiring synchronous encounters: Some states now mandate at least one live video or phone consultation before a weight-loss medication can be prescribed via telehealth. Check your state's medical board website for current requirements.
- States restricting compounded medications: A few states have introduced additional restrictions on dispensing compounded GLP-1 medications across state lines, particularly as FDA enforcement actions have increased.
- States with board of pharmacy enforcement: State pharmacy boards in several jurisdictions have issued guidance or warnings about compounding pharmacies that ship GLP-1 medications into their states without proper licensing.
How to Check Your State's Rules
- Your state medical board website will have current telehealth prescribing guidelines. Search for "[your state] medical board telehealth prescribing."
- Your state board of pharmacy may have separate rules about compounded medications shipped from out-of-state pharmacies.
- Ask the provider directly. Before starting an intake, confirm that they can prescribe and ship to your specific state. Don't assume that "available in all 50 states" language on a website is accurate — it may refer to brand-name only and not compounded products.
Providers With Broad State Coverage
Yucca Health
Yucca offers compounded GLP-1 programs with coverage across most states. Semaglutide plans start from $146/month on a 6-month plan. Verify your state's availability during their intake process.
Check Yucca Availability →Paid link · Compounded medications are not FDA-approved.
Oak Weight Loss
Full-service GLP-1 program with licensed prescribers. Their intake process confirms state eligibility before you proceed to payment.
Start Oak Intake →Paid link
Strut Health
Strut offers both injectable and sublingual compounded GLP-1 options across multiple verticals. Check state availability during their online intake.
See Strut Options →Paid link · Compounded medications are not FDA-approved.
Find Providers in Your State
Compare GLP-1 telehealth providers by state availability and prescribing model.
View Provider Directory